Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for KM Pharmacy Co. Ltd. (225430:KRX), powered by AI.
KM Pharmacy Co. Ltd. is currently trading at ₩3,035. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for KM Pharmacy Co. Ltd. on Alpha Lenz.
KM Pharmacy Co. Ltd.'s P/E ratio is -4.3.
“KM Pharmacy Co. Ltd. trades at a P/E of -4.3 (undervalued) with modest ROE of -13.0%.”
Ask for details →KM Pharmacy Co. Ltd. is a prominent player in the pharmaceutical sector, primarily focused on the distribution and retail of pharmaceutical products. The company's main function is to provide an extensive range of medicinal goods and health-related products to consumers, ensuring accessibility and availability in the healthcare market. KM Pharmacy is recognized for its comprehensive network of pharmacies that cater to the needs of a diverse customer base, including individuals seeking prescription medicines, over-the-counter (OTC) drugs, as well as health and wellness products. This company plays a significant role in the healthcare supply chain, impacting sectors such as healthcare services, consumer health, and wellness industries. By ensuring timely delivery and stocking of essential drugs, KM Pharmacy contributes to the overall efficiency of healthcare services. With a business model centered around customer service and product reliability, KM Pharmacy Co. Ltd. is an integral part of the healthcare infrastructure, supporting patient care and pharmaceutical logistics. Its presence in the market is crucial for maintaining steady drug availability, thereby influencing the broader pharmaceutical and consumer health markets.
“KM Pharmacy Co. Ltd. trades at a P/E of -4.3 (undervalued) with modest ROE of -13.0%.”
Ask for details →KM Pharmacy Co. Ltd. (ticker: 225430) is a company listed on KRX in the Financial Services sector (Asset Management). Market cap is $16.9B.
The current price is ₩3,035 with a P/E ratio of -4.27x and P/B of 0.6x.
ROE is -13.04% and operating margin is -18.28%. Annual revenue is $16.0B.